Circulating Ang-2 mRNA Expression Levels: Looking Ahead to a New Prognostic Factor for NSCLC
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Circulating Ang-2 mRNA Expression Levels: Looking Ahead to a New Prognostic Factor for NSCLC
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 2, Pages e90009
Publisher
Public Library of Science (PLoS)
Online
2014-03-01
DOI
10.1371/journal.pone.0090009
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting Angiogenesis in Advanced Non-Small Cell Lung Cancer
- (2017) Philip E. Lammers et al. Journal of the National Comprehensive Cancer Network
- Angiopoietin-2: An Attractive Target for Improved Antiangiogenic Tumor Therapy
- (2013) D. Gerald et al. CANCER RESEARCH
- Genotyping and Genomic Profiling of Non–Small-Cell Lung Cancer: Implications for Current and Future Therapies
- (2013) Tianhong Li et al. JOURNAL OF CLINICAL ONCOLOGY
- Management of non-small-cell lung cancer: recent developments
- (2013) Martin Reck et al. LANCET
- Genetics and biomarkers in personalisation of lung cancer treatment
- (2013) Rafael Rosell et al. LANCET
- A Novel Angiopoietin-2 Selective Fully Human Antibody with Potent Anti-Tumoral and Anti-Angiogenic Efficacy and Superior Side Effect Profile Compared to Pan-Angiopoietin-1/-2 Inhibitors
- (2013) Markus Thomas et al. PLoS One
- Angiopoietins in angiogenesis
- (2012) Ernesta Fagiani et al. CANCER LETTERS
- Predictive Impact of Circulating Vascular Endothelial Growth Factor in Four Phase III Trials Evaluating Bevacizumab
- (2012) P. S. Hegde et al. CLINICAL CANCER RESEARCH
- Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling
- (2012) Moritz Felcht et al. JOURNAL OF CLINICAL INVESTIGATION
- A novel angiopoietin-derived peptide displays anti-angiogenic activity and inhibits tumour-induced and retinal neovascularization
- (2011) GM Palmer et al. BRITISH JOURNAL OF PHARMACOLOGY
- Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical research
- (2011) Maria Bonomi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Non-small-cell lung cancer
- (2011) Peter Goldstraw et al. LANCET
- A Human Neutralizing Antibody Specific to Ang-2 Inhibits Ocular Angiogenesis
- (2011) EMMA S. RENNEL et al. MICROCIRCULATION
- Prognostic Impacts of Angiopoietins in NSCLC Tumor Cells and Stroma: VEGF-A Impact Is Strongly Associated with Ang-2
- (2011) Sigve Andersen et al. PLoS One
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
- (2010) Eunice L. Kwak et al. NEW ENGLAND JOURNAL OF MEDICINE
- Contrasting Actions of Selective Inhibitors of Angiopoietin-1 and Angiopoietin-2 on the Normalization of Tumor Blood Vessels
- (2009) Beverly L. Falcón et al. AMERICAN JOURNAL OF PATHOLOGY
- Serum Levels of Angiopoietin-1, Angiopoietin-2, and Their Receptor Tie-2 in Patients with Nonsmall Cell Lung Cancer During Chemotherapy
- (2009) Wojciech Naumnik et al. CANCER INVESTIGATION
- Host-Derived Angiopoietin-2 Affects Early Stages of Tumor Development and Vessel Maturation but Is Dispensable for Later Stages of Tumor Growth
- (2009) Patrick Nasarre et al. CANCER RESEARCH
- Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system
- (2009) Hellmut G. Augustin et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search